Myriad Genetics Inc Earnings
The next earnings date for Myriad Genetics Inc has not yet been scheduled.
Analyst Estimates of Myriad Genetics Inc Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Myriad Genetics Inc Earnings: Historical
| 07/30/2026 | After Market | $-0.33 | -312.50% |
| 05/05/2026 | After Market | $-0.09 | -28.57% |
| 02/23/2026 | --- | $0.04 | 332.56% |
| 11/03/2025 | After Market | $-0.29 | -2,800.00% |
| 08/05/2025 | After Market | $0.05 | 600.00% |
| 05/06/2025 | After Market | $-0.03 | 40.00% |
| 02/25/2025 | Before Market | $0.03 | -0.99% |
| 11/07/2024 | After Market | $0.06 | 200.00% |
| 08/06/2024 | After Market | $0.05 | 600.00% |
| 05/07/2024 | After Market | $-0.01 | 90.91% |
More About Myriad Genetics Inc
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor Molecular Profile test, a genomic profiling test; Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus; Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek Early Gender DNA test, a non-invasive blood test that predicts the gender of a fetus; FirstGene; and GeneSight Psychotropic Mental Health Medication test, a DNA genotyping test to aid psychotropic drug selection for depression, anxiety, attention-deficit/hyperactivity disorder, and other mental health conditions. It has a license collaboration with Illumina, Inc.; University of Texas M.D. Anderson Cancer Center; Mayo Foundation for Medical Education and Research; Children's Medical Center in Boston; Institut Curie and INSERM; and Eurobio Scientific SA. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.
“Myriad Genetics Inc Earnings” Can Refer to the Myriad Genetics Inc Earnings Date
Some people say “Myriad Genetics Inc earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Myriad Genetics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Myriad Genetics Inc Stock on the Earnings Date
If you own Myriad Genetics Inc stock (MYGN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Myriad Genetics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Myriad Genetics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Myriad Genetics Inc Earnings
You can contact us any time if you would like to ask questions about Myriad Genetics Inc earnings or anything else related to the stock market.